-
Full Article (HTML) (117) -
Full Article (PDF) (69) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4774)
All Articles published online
|
Publishing Process of This Article
|
May 18, 2016 (publication date) through Aug 12, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yi PS, Zhang M, Zhao JT, Xu MQ. Liver resection for intermediate hepatocellular carcinoma. World J Hepatol 2016; 8(14): 607-615 [PMID: 27190577 DOI: 10.4254/wjh.v8.i14.607] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i14/607.htm |
| Number | Citing Articles |
| 1 |
David Calatayud, Santiago Sánchez Cabús, Jaime Sampson, Aridai Resendiz, Victor Molina, Constantino Fondevila, Josep Fuster, Juan Carlos García-Valdecasas. Resección hepática mayor: una cirugía segura y eficaz. Cirugía Española 2017; 95(8): 437 doi: 10.1016/j.ciresp.2017.06.006
|
| 2 |
Zhou-wei Xu, Shang-xue Yan, Hua-xun Wu, Ying Zhang, Wei Wei. Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expression. Digestive and Liver Disease 2019; 51(2): 263 doi: 10.1016/j.dld.2018.06.007
|
| 3 |
G.K. Glantzounis, A. Paliouras, M.-C. Stylianidi, H. Milionis, P. Tzimas, D. Roukos, G. Pentheroudakis, E. Felekouras. The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review. European Journal of Surgical Oncology 2018; 44(2): 195 doi: 10.1016/j.ejso.2017.11.022
|
| 4 |
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan, Jian Shui Li. Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2019; 54(2): 240 doi: 10.1080/00365521.2019.1577487
|
| 5 |
David Calatayud, Santiago Sánchez Cabús, Jaime Sampson, Aridai Resendiz, Victor Molina, Constantino Fondevila, Josep Fuster, Juan Carlos García-Valdecasas. Hepatic Resection: A Safe and Effective Surgery. Cirugía Española (English Edition) 2017; 95(8): 437 doi: 10.1016/j.cireng.2017.10.007
|
| 6 |
Wenbo Guo, Song Chen, Zhiqiang Wu, Wenquan Zhuang, Jianyong Yang. Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study. Technology in Cancer Research & Treatment 2020; 19: 153303382096558 doi: 10.1177/1533033820965587
|
| 7 |
Yang Gu, Baiyang Chen, Deliang Guo, Leyu Pan, Xiaofeng Luo, Jie Tang, Weihua Yang, Yuxian Zhang, Liangqiang Zhang, Jingwen Huang, Rui Duan, Zhigang Wang, Junmin Zhang. Up-Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/3034150
|
| 8 |
De-Dong Cao, Hui-Lin Xu, Liang Liu, Yong-Fa Zheng, Si-Fa Gao, Xi-Ming Xu, Wei Ge. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(27): 44976 doi: 10.18632/oncotarget.16689
|
| 9 |
H Kim, S W Ahn, S K Hong, K C Yoon, H-S Kim, Y R Choi, H W Lee, N-J Yi, K-W Lee, K-S Suh. Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. British Journal of Surgery 2017; 104(8): 1045 doi: 10.1002/bjs.10541
|